Filing Category: Bylaw/Charter Amendment

  • TELEPHONE & DATA SYSTEMS INC /DE/ 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • The Telephone and Data Systems, Inc. (TDS) 2025 Executive Officer Bonus Program was approved by the TDS Compensation and Human Resources Committee on March 12, 2025.
    • The 2025 Plan covers the Vice Chair of TDS, all TDS executive vice president and senior vice president officers, and the President and CEO of TDS Telecommunications LLC (TDS Telecom), a wholly-owned subsidiary of TDS.
    • The 2025 Plan provides performance measures and weightings, of which 80% are based on company performance measures and 20% are based on individual performance.
    • On March 13, 2025, the Board of Directors of TDS adopted amendments to the Bylaws of TDS, as amended and restated as of January 24, 2025, which became effective immediately.
    • The Amendments provide that in the event the Chair or the President are absent or unable to act, the Vice Chair may take specified actions such as calling a special stockholder meeting, chairing a stockholder meeting, calling and chairing meetings of the Board of Directors, and invoking the emergency bylaw provisions.
    • The Amendments also provide that the Vice Chair position is an officer position and subject to the supervision of the Chair.
    • Additionally, the Amendments provide that in the event of the absence of the President or his or her inability or refusal to act as President or in the event of his or her earlier death, resignation, removal or disqualification, then the Vice Chair will automatically succeed to and perform the duties of the President.
    • Finally, the Amendments provide that the lead independent director may chair Board meetings in the event the Chair or President, or Vice Chair, are absent or unable to act.
  • Fly-E Group, Inc. 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • Stockholders approved the Fly-E Group, Inc. 2024 Omnibus Incentive Plan, as amended.
    • An amendment to the Certificate of Incorporation to effect a reverse stock split of the Company’s issued and outstanding shares of common stock by a ratio in a range of 1-for-2 to 1-for-15 was approved; the board will determine the ratio and timing within one year.
    • Stockholders approved an amendment to the Certificate of Incorporation to increase the authorized shares of common stock of the Company from 100,000,000 shares to 300,000,000 shares.
    • An amendment to the Certificate of Incorporation to classify the board of directors of the Company into three classes with staggered three-year terms was approved.
  • IMAC Holdings, Inc. 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • IMAC Holdings issued a promissory note to Jeffrey M. Busch, the Chair of the Board, for $27,500 and promissory notes to other lenders for $101,500.
    • The notes are unsecured and mature on the earlier of a securities offering with gross proceeds of at least $1,000,000 or November 14, 2025.
    • The company received a notice from Nasdaq because its common stock price was below $1.00 for 30 consecutive trading days.
    • IMAC Holdings has until September 9, 2025, to regain compliance with the minimum bid price requirement.
    • The company intends to take steps to regain compliance, including a potential reverse stock split, subject to stockholder approval on March 26, 2025.
    • The Board of Directors approved an amendment to the company’s bylaws, lowering the required quorum for stockholder meetings from a majority to one-third of the votes.

    Potential Implications

    Stock Price

    • The Nasdaq notice of non-compliance could negatively impact the stock price in the short term.
    • The company’s efforts to regain compliance, including a potential reverse stock split, could influence the stock price.
  • LAKE SHORE BANCORP, INC. 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • Lake Shore Savings Bank entered into an employment agreement with Taylor M. Gilden, Chief Financial Officer and Treasurer, with an initial term until December 16, 2027, and potential renewals.
    • Mr. Gilden’s annual base salary is $265,000, with eligibility for performance-based cash bonuses and long-term incentive compensation.
    • The agreement outlines severance payments for various termination scenarios, including voluntary termination, involuntary termination, and termination following a change in control.
    • Lake Shore, MHC, Lake Shore Bancorp, Inc., and Lake Shore Savings Bank amended the Plan of Conversion and Reorganization to increase individual and group purchase limits from $750,000 to $1,500,000.
    • The Board of Directors determined to suspend the payment of cash dividends pending the completion of the second-step conversion.
    • Following completion of the second-step conversion, the Company intends to resume paying cash dividends on its shares of common stock, subject to capital requirements, the Company’s financial condition and results of operations, tax considerations, statutory and regulatory limitations, and general economic conditions.

    Potential Implications

    Company Performance

    • The employment agreement with the CFO provides stability in leadership, potentially contributing to consistent financial management.
    • The suspension of dividends may free up capital for reinvestment in the company, potentially supporting future growth initiatives.
    • The second-step conversion to a fully-public stock holding company structure could provide greater flexibility for corporate transactions and access to capital markets.

    Stock Price

    • The suspension of dividends could negatively impact the stock price in the short term, as investors may seek income-generating investments elsewhere.
    • The increased purchase limits in the Plan of Conversion and Reorganization may stimulate demand for the company’s stock during the conversion process.
    • Successful completion of the second-step conversion and resumption of dividend payments could positively influence the stock price in the long term.
  • OFFICE PROPERTIES INCOME TRUST 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • Office Properties Income Trust (OPI) entered into a sales agreement with Clear Street LLC, allowing the company to issue and sell up to $100,000,000 of its common shares through an “at the market offering”.
    • The sales will be made under OPI’s shelf registration statement on Form S-3, including the prospectus and related supplements.
    • Clear Street LLC will receive a cash commission of 3.0% of the gross sales price for any common shares sold under the agreement, and will be reimbursed for certain expenses.
    • OPI intends to use the net proceeds from the sales of common shares for general business purposes.
    • OPI increased the number of authorized common shares from 200,000,000 to 250,000,000 via an amendment to its Amended and Restated Declaration of Trust.
  • Outlook Therapeutics, Inc. 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • Outlook Therapeutics closed a $33.1 million unsecured convertible promissory note with Avondale Capital, LLC, and used the proceeds to fully repay its existing debt of $32,910,027.57 to Streeterville Capital, LLC.
    • The company’s stockholders approved an amendment to the Restated Certificate of Incorporation to increase the authorized number of common stock shares from 60,000,000 to 260,000,000.
    • At the Annual Meeting, stockholders elected Julian Gangolli, Ralph H. “Randy” Thurman, and Lawrence A. Kenyon to serve as Class III directors until the 2028 Annual Meeting.
    • Stockholders approved the potential issuance of common stock exceeding 19.99% upon conversion of the new convertible note, even if the conversion price is below the Nasdaq minimum price.
    • KPMG LLP was ratified as the company’s independent registered public accounting firm for the fiscal year ending September 30, 2025.
    • A non-binding advisory vote on the compensation of the Company’s named executive officers was approved.
  • MULLEN AUTOMOTIVE INC. 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • Stockholders approved an amendment to the 2022 Equity Incentive Plan, increasing the maximum aggregate number of shares available for grant by 20,000,000 shares.
    • Stockholders approved a ten percent automatic annual increase in the total number of shares of Common Stock available for issuance under the 2022 Plan.
    • Stockholders approved amendments to the Performance Stock Award Agreements with the CEO, extending the deadlines for achieving certain milestones related to capital raising, vehicle completion, revenue generation, battery development, and JV-Acquisition.
    • Stockholders elected David Michery, Ignacio Novoa, and Mary Winter as Class I Directors to serve for a three-year term ending as of the annual meeting in 2028.
    • Stockholders approved proposals related to the issuance of shares of Common Stock pursuant to senior secured convertible notes and related warrants, exceeding certain share caps.
    • Stockholders approved an amendment to increase the number of shares of Common Stock authorized for issuance under the 2022 Plan by 20,000,000 shares.
    • Stockholders approved a second amendment to the 2022 Plan for the adoption of an automatic annual increase in the shares of Common Stock available for issuance under the 2022 Plan.
    • Stockholders approved the amendment of the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s outstanding Common Stock at an exchange ratio between 1-for-2 to 1-for-100, as determined by the Company’s Board of Directors.
    • Stockholders ratified the appointment of RBSM LLP as the independent registered public accounting firm of the Company for the fiscal year ending September 30, 2025.
    • Stockholders did not approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to increase the authorized number of shares of preferred stock to 1,000,000,000.
  • Pacira BioSciences, Inc. 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • The Board of Directors of Pacira BioSciences approved and adopted the Third Amended and Restated Bylaws.
    • The Third Amended and Restated Bylaws are effective immediately as of March 12, 2025.
    • The key change in the bylaws is the adoption of a majority voting standard for the election of director nominees in uncontested elections.
    • A plurality vote standard is retained for contested director elections.
    • No other changes were made to the Second Amended and Restated Bylaws.
  • Celanese Corp 8-K Analysis & Summary – 3/14/2025

    Analyst Summary

    • Celanese Corporation amended Article VIII, Section 8.01 of its bylaws, effective immediately on March 14, 2025.
    • The amendment designates the federal district courts of the United States as the sole and exclusive forum for claims arising under the Securities Act of 1933.
    • If the federal forum provision is deemed illegal, invalid, or unenforceable, the Court of Chancery of the State of Delaware will be the exclusive state court forum.